DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Bought by Pinebridge Investments L.P.

Pinebridge Investments L.P. grew its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 42.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 90,843 shares of the medical instruments supplier's stock after purchasing an additional 27,172 shares during the quarter. Pinebridge Investments L.P.'s holdings in DENTSPLY SIRONA were worth $1,724,000 as of its most recent filing with the SEC.

Other large investors have also modified their holdings of the company. Price T Rowe Associates Inc. MD raised its stake in DENTSPLY SIRONA by 18.7% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier's stock valued at $238,186,000 after buying an additional 1,975,404 shares in the last quarter. Eversept Partners LP bought a new stake in shares of DENTSPLY SIRONA in the 4th quarter valued at approximately $2,651,000. Tower Research Capital LLC TRC increased its holdings in shares of DENTSPLY SIRONA by 602.3% in the 4th quarter. Tower Research Capital LLC TRC now owns 26,372 shares of the medical instruments supplier's stock valued at $501,000 after acquiring an additional 22,617 shares during the last quarter. MetLife Investment Management LLC raised its position in shares of DENTSPLY SIRONA by 7.0% during the 4th quarter. MetLife Investment Management LLC now owns 112,113 shares of the medical instruments supplier's stock valued at $2,128,000 after acquiring an additional 7,351 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its stake in DENTSPLY SIRONA by 21.9% during the fourth quarter. Dimensional Fund Advisors LP now owns 6,851,869 shares of the medical instruments supplier's stock worth $130,045,000 after purchasing an additional 1,230,944 shares during the last quarter. Institutional investors own 95.70% of the company's stock.

Insider Activity

In other news, Director Gregory T. Lucier bought 15,142 shares of the firm's stock in a transaction that occurred on Monday, March 3rd. The stock was acquired at an average price of $16.51 per share, with a total value of $249,994.42. Following the completion of the purchase, the director now directly owns 81,971 shares of the company's stock, valued at $1,353,341.21. This represents a 22.66 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. 0.52% of the stock is owned by insiders.

DENTSPLY SIRONA Price Performance

Shares of DENTSPLY SIRONA stock traded up $0.03 on Thursday, hitting $13.93. The company had a trading volume of 3,200,700 shares, compared to its average volume of 2,977,454. DENTSPLY SIRONA Inc. has a 52 week low of $12.16 and a 52 week high of $30.78. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The company has a market cap of $2.78 billion, a PE ratio of -6.73, a PEG ratio of 1.80 and a beta of 0.92. The business has a 50-day simple moving average of $14.69 and a 200-day simple moving average of $18.04.

DENTSPLY SIRONA Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 4.59%. The ex-dividend date of this dividend was Friday, March 28th. DENTSPLY SIRONA's payout ratio is currently -14.07%.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on XRAY shares. Wells Fargo & Company dropped their target price on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating on the stock in a report on Friday, February 28th. Robert W. Baird dropped their price objective on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a research note on Friday, February 28th. Piper Sandler decreased their target price on DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating for the company in a research note on Wednesday. Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. Finally, Morgan Stanley lowered DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price objective for the company. in a research report on Tuesday, April 15th. Thirteen analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, DENTSPLY SIRONA currently has a consensus rating of "Hold" and an average price target of $21.25.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.